ASCO Annual Meeting 2026

CON-0001International congressCompletedAmber29 May 2026 – 02 Jun 2026

DCDavid ChenHead of Medical Communications

Organiser: American Society of Clinical Oncology
Type: International congress
Location: Chicago, IL, US
Dates: 29 May 2026 – 02 Jun 2026
Therapeutic area: Oncology
Products: Vantrexa
Objectives: SO-VTX-01
Target stakeholder groups: Thoracic oncologists, Pathologists

Planned activities

2 oral presentations
Medical booth
18 KOL meetings
Advisory board (sequencing)

Scientific outputs

Presentations

Abstracts

Advisory boards

Attendee plan

Planned

Actual

100% of plan

Linked publications (0)

No publications target "ASCO"

Engagement plan

21 completed of 18 planned · congress meetings recorded 27 May 2026 – 04 Jun 2026

117%

Date	Stakeholder	MSL	Topics	Status
29 May 2026	Dr. Rosa Kimura	Mei Tanaka	PD-L1 testing turnaround, Duration of response, Elderly / ECOG 2 patients	Reviewed

Insights captured

Count on record: 14

Insight	Topic	Status
INS-0022	Comparator checkpoint monotherapy	Closed

Post-event actions

14 of 16 completed

88%

Post-event action 1Completed
Post-event action 2Completed
Post-event action 3Completed
Post-event action 4Completed
Post-event action 5Completed
Post-event action 6Completed
Post-event action 7Completed
Post-event action 8Completed
Post-event action 9Completed
Post-event action 10Completed
Post-event action 11Completed
Post-event action 12Completed
Post-event action 13Completed
Post-event action 14Completed
Post-event action 15Open
Post-event action 16Open

Budget variance

Budget

$480k

Spend to date

$462k

96% consumed

Variance

−$18k

Under budget

96%

Event performance summary

Amber

Engagements 117% of plan, follow-ups 88% complete, attendance 100% of plan, $18k under budget.

RAG derived from the lowest of engagement, follow-up and attendance completion ratios (Green ≥ 90%, Amber ≥ 60%); budget overrun caps at Amber.

Audit history

No audit events for this record

Create, update, approve and export events appear here with user, timestamp, previous and new values.

Date

Stakeholder

MSL

Topics

Status

29 May 2026

Dr. Rosa Kimura

Mei Tanaka

PD-L1 testing turnaround, Duration of response, Elderly / ECOG 2 patients

Reviewed

Insight

Topic

Status

INS-0022

Comparator checkpoint monotherapy

Closed